Sign in
PLXP Stock Price, Chart, Stats & News
PLx Pharma Inc.
Save
2.53M
Market cap
–
Current P/E
–
Forward P/E
PLXP chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 41.46% |
Operating margin | -496.95% |
Pretax margin | -561.95% |
Net margin | -626.95% |
Effective tax rate | -11.57% |
ROA | -67.14% |
ROE | -165.64% |
D/E | – |
Interest coverage ratio | -40790.00x |
PLXP valuation
P/E | – |
P/S | 0.31x |
P/B | 0.04x |
P/CF | -0.06x |
P/FCF | -0.08x |
P/OCF | -0.06x |
PEG | -0.00x |
EV multiple | -2.04x |
About
PLx Pharma Inc. is a U. S.-based entity leveraging its innovative drug delivery platform technology, having successfully transitioned into the commercial stage. The company's primary offerings include Vazalore 325 mg, which is formulated for individuals facing vascular incidents like heart attacks and clot-induced strokes, as well as for the management of pain and inflammation.
Similar securities
Based on sector and market capitalization
Report issue